Pain Sensitivity and Pruritus of Peripheral Nerves
Pain Sensitivity and Pruritus of Peripheral Nerves - Can we Differentiate These Signals by Use of Pharmacological Modulation and Human Experimental Research?
Previous research has demonstrated that itch and pain share several underlying neural pathways and signaling molecules. Understanding these common mechanisms is important for developing more effective therapeutic strategies targeting both sensations. Mepyramine, an antihistamine, has been reported to exert effects on both itch and pain perception. This study aims to investigate these effects using established experimental models of itch and pain. Itch will be induced using histamine, a naturally occurring substance in the human body, and spicules from the plant Mucuna pruriens (cowhage), while electrical stimulation will be used to assess pain-related responses. By combining these experimentais approaches, the project aims to better understand how mepyramine influences different sensory mechanisms. The overall purpose of this study is to evaluate the effects of mepyramine on experimentally induced itch and pain in healthy volunteers.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Effettivo)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Aalborg
-
Gistrup, Aalborg, Danimarca, 9260
- Center for Neuroplasticity and Pain Faculty of Medicine, Aalborg University Selma Lagerløfs Vej 249 9260 Gistrup, Denmark
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Healthy men and women aged 18-60 years
- Speak and understand English
Exclusion Criteria:
-
Pregnancy or lactation
-
Drug addiction defined as any use of cannabis, opioids, or other drugs that may cause addiction.
-
History of peripheral or chronic pain conditions, neuropathy, neurological, dermatological, or psychiatric diagnoses that may affect the results.
- Moles, wounds, scars, or tattoos in the area to be treated or tested
- Current use of medications that may affect the trial such as antihistamines, painkillers, antidepressants, or anticonvulsants
- Use of antihistamines should be discontinued 72 hours before the experiment and all topical agents and emollients should be discontinued 24 hours before the experiment.
- Application of moisturizing lotion of the volar site of the forearms (24 hours before study start)
- Previous traumatic experience of an electrical accident
- Participation in any other research projects/studies 7 days before study start
- Known allergy/intolerance to mepyramine
- The subject is assessed as unable to engage in the necessary cooperation required by the study
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Scienza basilare
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Interventions
This subproject will be conducted in one single session lasting approximately 4-5 hours. In each forearm of the participant, two 4x4 cm areas will be selected as Area of Interest (AOI). In these selected areas, the same cream will be applied for 1 hour. After the cream removal, itch will be induced using histamine and cowhage (the order of histamine and cowhage will be randomized). During the application of the substances, the itch/pain elicited will be monitored for 10 minutes using a VAS (Visual analog scale). After the removal of the substances, measurements of SBP, MEI, PTT MPT, MPS, and thermal sensitivity will be conducted. |
About 30 spicules will be applied on the selected areas and inserted manually Mepyramine cream 2% One drop of histamine will be applied on the selected areas and pierced with a lancet. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Measuring itch by computerized Visual Analog Scale Scoring
Lasso di tempo: During Histamine/cowhage application
|
We will ask the subjects to rate the sensation of itch on a 100 mm VAS scale ranging from 0 to 100 where 0 indicates |
During Histamine/cowhage application
|
|
Superficial blood perfusion
Lasso di tempo: Before pruritogen application
|
Before pruritogen application
|
|
|
Superficial blood perfusion
Lasso di tempo: 1 minute after pruritogen removal
|
1 minute after pruritogen removal
|
|
|
Superficial blood perfusion
Lasso di tempo: 1 minute after cream+pruritogen removal
|
1 minute after cream+pruritogen removal
|
|
|
Perception threshold tracking model (PTT)
Lasso di tempo: Before cream application
|
Before cream application
|
|
|
Perception threshold tracking model (PTT)
Lasso di tempo: 1 minute after cream removal
|
1 minute after cream removal
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Mechanically evoked itch (MEI)
Lasso di tempo: 2 minute after pruritogen removal
|
MEI is measured by using mildly pruritic, non-painful von Frey nylon filaments of a predetermined intensity (generally 5-30 miliNewton of force). |
2 minute after pruritogen removal
|
|
Mechanically evoked itch (MEI)
Lasso di tempo: 2 minute after cream+pruritogen removal
|
MEI is measured by using mildly pruritic, non-painful von Frey nylon filaments of a predetermined intensity (generally 5-30 miliNewton of force). |
2 minute after cream+pruritogen removal
|
|
Mechanical Pain Thresholds (MPT)
Lasso di tempo: 5 minute after pruritogen removal
|
This test is conducted using a pinprick set. The set consists of 7 needles each with a diameter of 0.6 mm and different force applications: 8, 16, 32, 64, 128, 256, and 512 mN. |
5 minute after pruritogen removal
|
|
Mechanical Pain Thresholds (MPT)
Lasso di tempo: 5 minute after cream+pruritogen removal
|
This test is conducted using a pinprick set. The set consists of 7 needles each with a diameter of 0.6 mm and different force applications: 8, 16, 32, 64, 128, 256, and 512 mN. |
5 minute after cream+pruritogen removal
|
|
Mechanical Pain Sensitivity (MPS)
Lasso di tempo: 8 minute after pruritogen removal
|
This test is conducted with the same pinprick set used to test the MPT. |
8 minute after pruritogen removal
|
|
Mechanical Pain Sensitivity (MPS)
Lasso di tempo: 8 minute after cream+pruritogen removal
|
This test is conducted with the same pinprick set used to test the MPT. |
8 minute after cream+pruritogen removal
|
|
Cold Detection Thresholds (CDT)
Lasso di tempo: 10 minute after pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after pruritogen removal
|
|
Cold Detection Thresholds (CDT)
Lasso di tempo: 10 minute after cream+pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after cream+pruritogen removal
|
|
Warm Detection Thresholds (WDT)
Lasso di tempo: 10 minute after pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after pruritogen removal
|
|
Warm Detection Thresholds (WDT)
Lasso di tempo: 10 minute after cream+pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after cream+pruritogen removal
|
|
Cold Pain Thresholds (CPT)
Lasso di tempo: 10 minute after pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after pruritogen removal
|
|
Cold Pain Thresholds (CPT)
Lasso di tempo: 10 minute after cream+pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after cream+pruritogen removal
|
|
Heat Pain Thresholds (HPT)
Lasso di tempo: 10 minute after pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after pruritogen removal
|
|
Heat Pain Thresholds (HPT)
Lasso di tempo: 10 minute after cream+pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after cream+pruritogen removal
|
|
Pain to Supra-threshold Heat Stimuli (STHS)
Lasso di tempo: 10 minute after pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after pruritogen removal
|
|
Pain to Supra-threshold Heat Stimuli (STHS)
Lasso di tempo: 10 minute after cream+pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after cream+pruritogen removal
|
Collaboratori e investigatori
Sponsor
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- N-20260019
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .